RNA Processing in Cancer Conference: From Bench to Bedside

癌症会议中的 RNA 处理：从实验室到临床

基本信息

批准号：
10752111
负责人：
OLGA ANCZUKOW-CAMARDA
金额：
$ 1.09万
依托单位：
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10752111
关键词：
Acceleration Alternative Splicing Area Biology Cancer Biology Career Mobility Cell physiology Clinical Collaborations Creativeness Defect Development Discipline Education Event Fostering Future Goals Immune response Immune system Industry Intention Knowledge Learning Malignant Neoplasms Modification Molecular Oncology Outcome Pathogenesis Pharmaceutical Preparations Pharmacologic Substance Physical condensation Physicians Postdoctoral Fellow Process RNA RNA Processing RNA Splicing RNA-targeting therapy Research Research Personnel Resources Role Schedule Scholarship Science Scientist Series Site Therapeutic Translations Underrepresented Minority Woman anticancer research bench to bedside cancer clinical trial cancer initiation career career development collaborative environment drug development graduate student high throughput technology interest lectures meetings next generation novel novel strategies novel therapeutic intervention posters pre-doctoral preclinical trial programs recruit response social symposium targeted cancer therapy therapeutic target tumorigenesis

项目摘要

SUMMARY Alterations in RNA processing have recently emerged as a new cancer hallmark and a promising target for cancer therapies. The fields of cancer and RNA biology have traditionally been studied in isolation; however, an integrated approach between these fields is needed to prepare the next generation of scientists and physicians to uncover the mechanisms of their relationship. Currently, no conference in the cancer field incorporates RNA biology. To fill this gap, we propose the unique and timely interdisciplinary conference “FASEB RNA processing in cancer: from bench to bedside” to foster future collaborations and research advances. The main objectives of this meeting are to define the role of RNA processing in cancer initiation, progression, and drug responses, and to identify novel therapeutic strategies to target RNA processing defects in cancer. This 5-day long conference to be held in Houston, TX in November 2023 will bring together scientists, including graduate students, postdoctoral fellows, and junior and senior investigators, as well as clinicians and physicians, and scientists from industry and pharmaceutical companies, from the fields of RNA biology and cancer. While putting together the speakers list, the organizing committee made a commitment to increased diversity. The conference program will include invited lectures, short talks from trainees, and educational/professional sessions, featuring leading scientists with distinct expertise yet shared interest in understanding the role of RNA processing in cancer pathogenesis and developing novel cancer therapeutics. Our specific aims are to (1) Organize an interdisciplinary conference on RNA processing and cancer; (2) Promote interactions to foster collaborative research and career advancement; (3) Foster the recruitment and development of diverse junior investigators in RNA biology and cancer research fields; (4) Accelerate translation of fundamental advances into novel clinical cancer therapeutics. The proposed conference will cross-pollinate the fields of RNA biology and cancer biology, seed new collaborations across disciplines, and facilitate the next generation of scientists to implement novel strategies towards targeting RNA processing in oncology.

概括 RNA加工的改变最近已成为一种新的癌症标志和一个有希望的靶标然而，癌症和 RNA 生物学领域传统上都是孤立研究的。需要在这些领域之间采取综合方法来培养下一代科学家和医生目前，癌症领域还没有会议涉及 RNA。为了填补这一空白，我们提出了独特且及时的跨学科会议“FASEB RNA 处理”。癌症：从实验室到临床”，以促进未来的合作和研究进展。本次会议的目的是定义 RNA 加工在癌症发生、进展和药物反应中的作用，并确定针对癌症 RNA 加工缺陷的新治疗策略。会议将于 2023 年 11 月在德克萨斯州休斯顿举行，科学家们将齐聚一堂，其中包括研究生学生、博士后研究员、初级和高级研究人员、以及新人和医生，以及来自工业界和制药公司、RNA 生物学和癌症领域的科学家。结合发言者名单，组委会承诺增加会议的多样性。计划将包括受邀讲座、学员简短演讲以及教育/专业会议，其中包括具有独特专业知识但对了解 RNA 加工在癌症中的作用有着共同兴趣的领先科学家我们的具体目标是（1）组织一个癌症发病机制和新的癌症治疗方法。 RNA加工和癌症跨学科会议；(2)促进互动以促进合作 (3) 促进多元化初级研究者的招募和培养 RNA生物学和癌症研究领域；（4）加速将基础进展转化为临床新成果；拟议的会议将在 RNA 生物学和癌症生物学领域进行交叉授粉，培育新的跨学科合作，并促进下一代科学家实施新的针对肿瘤学中 RNA 加工的策略。